Longeveron(LGVN) - 2022 Q4 - Earnings Call Transcript
Longeveron(LGVN)2023-03-10 23:40James Clavijo - CFO WaÂ'el Hashad - CEO Dr. Chris Min - Chief Medical Officer I would now like to turn the call over to James Clavijo, Longeveron's Chief Financial Officer. James, you may proceed. Thank you, James. Good morning, everyone. Welcome to Longeveron Fourth Quarter and full 2022 business update and financial results. Thank you for joining us today. Longeveron is a clinical stage biotechnology company, developing regenerative medicine for unmet medical needs. We believe that Lomecel-B has multiple ...